The chemical class termed PRSS34 Activators encompasses a diverse range of compounds that can influence the activity of PRSS34, a serine protease. This class includes molecules that function through various mechanisms to modulate the activity of PRSS34 within cellular environments. Some of these chemicals operate by activating kinases, which in turn can phosphorylate proteins, including serine proteases, thereby modulating their activity. Others act by altering intracellular signaling molecules such as cAMP, which is known to regulate a variety of proteins through kinase-dependent pathways. Additionally, alterations in calcium concentrations brought about by ionophores can initiate a cascade of intracellular events affecting enzyme activity.
Inhibitors of phosphatases and proteasomes are also considered within this class as they can lead to an increase in the phosphorylated state of proteins or an accumulation of proteins that require degradation, respectively. This can result in an environment conducive to the activation of PRSS34. Furthermore, the modulation of cellular signaling pathways that are integral to the regulation of protease expression and activity falls within the scope of PRSS34 Activators. By inhibiting key signaling molecules within these pathways, these compounds can create conditions that favor the activation of PRSS34. Collectively, these chemicals share the ability to alter the cellular milieu in a manner that can lead to increased activity of PRSS34, despite their diverse modes of action and the distinct molecular pathways they affect.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
PMA | 16561-29-8 | sc-3576 sc-3576A sc-3576B sc-3576C sc-3576D | 1 mg 5 mg 10 mg 25 mg 100 mg | $40.00 $129.00 $210.00 $490.00 $929.00 | 119 | |
PMA can activate protein kinase C (PKC), which may phosphorylate serine and threonine residues on various proteins, potentially affecting PRSS34 activity. | ||||||
Forskolin | 66575-29-9 | sc-3562 sc-3562A sc-3562B sc-3562C sc-3562D | 5 mg 50 mg 1 g 2 g 5 g | $76.00 $150.00 $725.00 $1385.00 $2050.00 | 73 | |
Forskolin activates adenylyl cyclase, increasing cAMP levels, which can regulate proteases through PKA-dependent signaling pathways, possibly activating PRSS34. | ||||||
Ionomycin | 56092-82-1 | sc-3592 sc-3592A | 1 mg 5 mg | $76.00 $265.00 | 80 | |
This calcium ionophore increases intracellular calcium concentration, which can affect various calcium-dependent processes, possibly activating PRSS34. | ||||||
Sodium Orthovanadate | 13721-39-6 | sc-3540 sc-3540B sc-3540A | 5 g 10 g 50 g | $45.00 $56.00 $183.00 | 142 | |
As a phosphatase inhibitor, it can prevent dephosphorylation of proteins, which can affect PRSS34 activity. | ||||||
Okadaic Acid | 78111-17-8 | sc-3513 sc-3513A sc-3513B | 25 µg 100 µg 1 mg | $285.00 $520.00 $1300.00 | 78 | |
This inhibitor of protein phosphatases 1 and 2A can alter phosphorylation states, possibly activating PRSS34. | ||||||
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $121.00 $392.00 | 148 | |
A PI3K inhibitor that can alter AKT signaling, possibly influencing PRSS34 activity. | ||||||
U-0126 | 109511-58-2 | sc-222395 sc-222395A | 1 mg 5 mg | $63.00 $241.00 | 136 | |
An inhibitor of MEK1/2, which are part of the MAPK pathway, could influence PRSS34 activity. | ||||||
SB 203580 | 152121-47-6 | sc-3533 sc-3533A | 1 mg 5 mg | $88.00 $342.00 | 284 | |
This p38 MAPK inhibitor may alter cellular responses and possibly activate PRSS34. | ||||||
MG-132 [Z-Leu- Leu-Leu-CHO] | 133407-82-6 | sc-201270 sc-201270A sc-201270B | 5 mg 25 mg 100 mg | $56.00 $260.00 $980.00 | 163 | |
A proteasome inhibitor that can lead to an accumulation of proteins within the cell, possibly affecting PRSS34 regulation. | ||||||
SP600125 | 129-56-6 | sc-200635 sc-200635A | 10 mg 50 mg | $40.00 $150.00 | 257 | |
An inhibitor of JNK, which is involved in stress responses and could activate PRSS34. | ||||||